中东和非洲基因合成市场见解和新兴趋势

中东和非洲基因合成市场

中东和非洲基因合成市场分析与洞察

基因合成是在实验室环境下利用合成生物学创造人工基因的过程。重组蛋白的生成是重组 DNA 技术的众多应用之一，其中基因合成正成为一种关键手段。传统的克隆和诱变方法正迅速被从头基因合成所取代，这种方法也能够生产没有模板的核酸。

中东和非洲基因合成市场

中东和非洲基因合成市场预计将在 2022 年至 2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在 2022 年至 2029 年的预测期内，该市场以 17.4% 的复合年增长率增长，预计将从 2021 年的 4553 万美元达到 2029 年的 1.6643 亿美元。

报告指标	细节
预测期	2022 至 2029 年
基准年	2021
历史岁月	2020（可定制至 2019 - 2014）
定量单位	收入（百万美元）
涵盖的领域	按组件（合成器、耗材、软件和服务）、基因类型（标准基因、表达基因、复杂基因等）、基因合成类型（基因文库合成、定制基因合成）、应用（合成生物学、基因工程、疫苗设计、治疗抗体等）、方法（固相合成、基于芯片的 DNA 合成、基于 PCR 的酶合成）、最终用户（学术和研究机构、诊断实验室、生物技术和制药公司等）、分销渠道（直接招标、在线分销和第三方分销商）
覆盖国家	南非、沙特阿拉伯、阿联酋、埃及、以色列、中东其他地区和非洲。
涵盖的市场参与者	其中包括Genescript、Synbio Technologies、Proteogenix、Bio Basic Inc.、ATG: biosynthetic GmbH、Merck KGaA、Ginkgo Bioworks、Evonetix、ProMab Biotechnologies, Inc.、CSBio 和 Azenta US, Inc.。

市场定义

基因合成是指 DNA 链逐个碱基的化学合成。与细胞内或通过聚合酶链式反应 (PCR)进行的 DNA 复制不同，基因合成不需要模板链。相反，基因合成涉及逐步将核苷酸添加到单链分子中，然后将其作为创建互补链的模板。基因合成是合成生物学领域的基础技术。

基因合成市场动态

本节旨在了解市场驱动因素、机遇、限制和挑战。以下内容将详细讨论所有这些内容：

驱动程序

慢性传染病患病率上升

由于全球传染病的流行率不断上升，细菌和病毒性疾病正在迅速蔓延。因此，对新型有效疗法的需求也随之增加，以对抗这些致命疾病。这些疾病可以通过化学药物和生物疗法（包括基因疗法）治愈。通过应用基因组学，传染病和地方病的管理得到了加强。它还使我们能够了解新出现的耐药性并确定新疗法和疫苗的目标。对于传染病的治疗，基因疗法吸引了许多研究人员，因为它可以通过重组 DNA 技术、DNA 和 RNA 核酶以及单链抗体进行治疗。

随着全球慢性传染病的发病率不断上升，对疫苗和有效基因治疗的需求也随之上升，这增加了对新基因的需求，这些基因在研究活动以及药物和疫苗制造中具有重要应用。因此，传染病的发病率不断上升，成为基因合成市场增长的驱动力。

基因治疗应用日益增多

基因治疗是一种先进的技术，包括使用多种基因来预防特定疾病类型。该技术涉及将基因插入患者细胞，而不是药物和手术。由于对新颖且持久的治疗效果的需求增加，基因治疗的采用正在增加。基因治疗需要合成基因构建体以及其他基因产品，以加速基因治疗的发展。由于遗传疾病的增加，对适当治疗的需求是一个主要因素，借助基因治疗，可以治愈特定疾病类型。

由于需求增加，领导者不断专注于生产基因治疗产品、获得批准和营销授权。

为了给不同类型的患者提供高质量的生活，人们对救命药物和疗法的需求巨大。这些不断增长的患者数量在很大程度上取决于可用的基因疗法来实现适当的治愈。要制造基因疗法，需要合成和新基因，这可以通过基因合成技术实现。因此，基因疗法的日益普及有望成为基因合成市场的驱动力。

合成生物学的扩展

将工程原理融入生物学被称为合成生物学。DNA 基因组可以在合成生物学的帮助下重新组装，因为它涉及通过将 DNA 与基因组结合来进行 DNA 的化学合成。通过结合使用基因合成服务、软件和消耗品，可以在短时间内构建寡核苷酸。随着全球对合成生物学产品的需求不断增加，基因合成产品和服务也在不断增加。

因此，由于其有效和创新的产品，全球对合成生物学产品的需求正在增加，这有望成为基因合成市场的驱动因素。

机会

医疗支出不断上涨

随着各国人民的可支配收入不断提高，全球医疗支出也随之增加。此外，为满足人口需求，政府部门和医疗机构正通过加快医疗支出来发挥主动作用。

此外，主要市场参与者采取的战略举措将为 2022-2029 年预测期内的医疗器械测试市场提供结构完整性和未来机会。

限制/挑战

基因合成过程成本高昂

然而，某些地区基因合成技术的壁垒和基因合成过程的高成本可能会阻碍基因合成程序的增长，从而阻碍市场的增长。此外，医疗技术行业的激烈竞争和海外资格认证的漫长准备时间可能是市场增长的挑战因素

本基因合成市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响，分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需了解有关基因合成市场的更多信息，请联系 Data Bridge Market Research 获取分析师简报。我们的团队将帮助您做出明智的市场决策，以实现市场增长。

近期发展

2020 年 12 月，Twist Bioscience 推出了可克隆的基因片段，以完善基因的供应。推出的片段可以与接头一起使用或不与接头一起使用，以构建完美的克隆。可克隆的基因片段与蛋白质表达途径、酶工程和基因表达等兼容。
根据 ACS 期刊发表的一篇文章，2020 年全球报告的癌症新发病例估计为 1930 万例，癌症死亡人数接近 1000 万例。这表明癌症覆盖率并不理想，迫切需要在全世界范围内实施高癌症覆盖率。

中东和非洲基因合成市场范围

中东和非洲基因合成市场细分为成分、基因类型、基因合成类型、应用、方法、最终用户和分销渠道。这些细分市场之间的增长将帮助您分析行业中增长微弱的细分市场，并为用户提供有价值的市场概览和市场洞察，以便做出战略决策，确定核心市场应用。

成分

合成器
耗材
软件和服务

根据组成部分，中东和非洲基因合成市场分为合成器、消耗品以及软件和服务。

基因类型

标准基因
表达基因
复合基因
其他的

根据基因类型，中东和非洲基因合成市场分为标准基因、表达基因、复杂基因和其他。

基因合成类型

基因文库合成
定制基因合成

根据基因合成类型，中东和非洲基因合成市场分为基因库合成和定制基因合成。

应用

合成生物学，
基因工程，
疫苗设计，
治疗性抗体
其他的

根据应用，中东和非洲基因合成市场细分为合成生物学、基因工程、疫苗设计、治疗性抗体等。

方法

固体合成，
基于芯片的 DNA 合成
基于PCR的酶合成

根据方法，中东和非洲基因合成市场分为固体合成、基于芯片的 DNA 合成和基于 PCR 的酶合成。

最终用户

学术及研究机构，
诊断实验室，
生物科技与制药公司
其他的

根据最终用户，中东和非洲基因合成市场分为学术和研究机构、诊断实验室、生物技术和制药公司等。

分销渠道

直接招标
网上分销
第三方分销商

基因合成市场

根据分销渠道，中东和非洲基因合成市场分为直接招标、在线分销和第三方分销商。

基因合成市场区域分析/见解

对基因合成市场进行了分析，并按国家、成分、基因类型、基因合成类型、应用、方法、最终用户和分销渠道提供了市场规模洞察和趋势，如上所述。

沙特阿拉伯在市场份额和市场收入方面占据基因合成市场的主导地位，并将在预测期内继续保持主导地位。这是由于该地区对基因合成过程的验证和确认的需求不断增加，而快速的研究发展正在推动市场

报告的国家部分还提供了影响市场当前和未来趋势的各个市场影响因素和市场法规变化。新旧销售、国家人口统计、疾病流行病学和进出口关税等数据点是预测各个国家市场情景的一些主要指标。此外，在对国家数据进行预测分析时，还考虑了全球品牌的存在和可用性以及它们因来自本地和国内品牌的激烈竞争而面临的挑战，以及销售渠道的影响。

竞争格局和基因合成市场份额分析

基因合成市场竞争格局提供了竞争对手的详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度以及应用主导地位。以上提供的数据点仅与专注于基因合成市场的公司有关。

基因合成市场的一些主要参与者包括 ATDBio Ltd（Biotage 的子公司）、General Biosystems, Inc.、MACROGEN CO., LTD.、Boster Biological Technology、Creative Biogene、Bioneer Pacific、exonbio、trenzyme GmbH、Twist Bioscience、BioCat GmbH（AddLife AB 的子公司）、OriGene Technologies, Inc.、Integrated DNA Technologies, Inc.（Danaher Corporation 的子公司）、Eurofins Scientific、NZYTech, Lda. - Genes and Enzymes、Ansa Biotechnologies, Inc.、Thermo Fisher Scientific、Genescript、Synbio Technologies、Proteogenix、Bio Basic Inc.、ATG:biosynthetics GmbH、Merck KGaA、Kaneka Eurogentec SA、Ginkgo Bioworks、Bbi-lifesciences、Evonetix、ProMab Biotechnologies, Inc.、GCC Biotech (INDIA) Pvt。 Ltd.、CSBio、Azenta US, Inc. 等。

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。使用市场统计和连贯模型分析和估计市场数据。此外，市场份额分析和关键趋势分析是市场报告中的主要成功因素。DBMR 研究团队使用的关键研究方法是数据三角测量，其中包括数据挖掘、数据变量对市场影响的分析以及主要（行业专家）验证。除此之外，数据模型还包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、公司市场份额分析、测量标准、中东和非洲与地区和供应商份额分析。如有进一步询问，请要求分析师致电。

SKU-62812

Get online access to the report on the World's First Market Intelligence Cloud

Click on image to enlarge

Interactive Data Analysis Dashboard
Company Analysis Dashboard for high growth potential opportunities
Research Analyst Access for customization & queries
Competitor Analysis with Interactive dashboard
Latest News, Updates & Trend analysis
Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking

Request for Demo

表格列表

TABLE 1 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 2 MIDDLE EAST & AFRICA SOFTWARE & SERVICES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 8 MIDDLE EAST & AFRICA STANDARD GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA COMPLEX GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA EXPRESS GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 13 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 15 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 17 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 18 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 20 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 24 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 26 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 28 MIDDLE EAST & AFRICA PCR-BASED ENZYME SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 MIDDLE EAST & AFRICA CHIP-BASED DNA SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 MIDDLE EAST & AFRICA SOLID BASED SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 32 MIDDLE EAST & AFRICA ACADEMIC & RESEARCH INSTITUTES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 MIDDLE EAST & AFRICA BIOTECH & PHARMACEUTICAL COMPANIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 MIDDLE EAST & AFRICA DIAGNOSTIC LABORATORIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 MIDDLE EAST & AFRICA OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 37 MIDDLE EAST & AFRICA DIRECT TENDER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 MIDDLE EAST & AFRICA ONLINE DISTRIBUTION IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 MIDDLE EAST & AFRICA THIRD PARTY DISTRIBUTORS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 41 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 42 MIDDLE EAST & AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 43 MIDDLE EAST & AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 45 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 46 MIDDLE EAST & AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 47 MIDDLE EAST & AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 48 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 49 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 50 MIDDLE EAST & AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 51 MIDDLE EAST & AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 52 MIDDLE EAST & AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 53 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 54 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 55 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 56 SAUDI ARABIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 57 SAUDI ARABIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 SAUDI ARABIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 SAUDI ARABIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 60 SAUDI ARABIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 61 SAUDI ARABIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 62 SAUDI ARABIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 63 SAUDI ARABIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 SAUDI ARABIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 65 SAUDI ARABIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 66 SAUDI ARABIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 67 SAUDI ARABIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 68 SAUDI ARABIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 69 SAUDI ARABIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 70 SAUDI ARABIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 71 SOUTH AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 72 SOUTH AFRICA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 73 SOUTH AFRICA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 74 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 75 SOUTH AFRICA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 76 SOUTH AFRICA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 77 SOUTH AFRICA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 78 SOUTH AFRICA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 79 SOUTH AFRICA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 80 SOUTH AFRICA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 81 SOUTH AFRICA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 82 SOUTH AFRICA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 83 SOUTH AFRICA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 84 SOUTH AFRICA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 85 SOUTH AFRICA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 86 U.A.E GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 87 U.A.E CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 88 U.A.E SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 89 U.A.E GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 90 U.A.E GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 91 U.A.E CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 92 U.A.E GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 93 U.A.E GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 94 U.A.E SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 95 U.A.E GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 96 U.A.E THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 97 U.A.E VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 98 U.A.E GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 99 U.A.E GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 100 U.A.E GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 101 ISRAEL GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 102 ISRAEL CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 ISRAEL SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 ISRAEL GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 105 ISRAEL GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 106 ISRAEL CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 107 ISRAEL GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 108 ISRAEL GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 ISRAEL SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 110 ISRAEL GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 111 ISRAEL THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 112 ISRAEL VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 113 ISRAEL GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 114 ISRAEL GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 115 ISRAEL GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 116 EGYPT GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 117 EGYPT CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 118 EGYPT SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 119 EGYPT GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 120 EGYPT GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 121 EGYPT CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 122 EGYPT GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 123 EGYPT GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 124 EGYPT SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 125 EGYPT GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 126 EGYPT THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 127 EGYPT VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 128 EGYPT GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 129 EGYPT GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 130 EGYPT GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 131 REST OF MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

图片列表

FIGURE 1 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SEGMENTATION

FIGURE 2 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: GEOGRAPHIC SCOPE

FIGURE 3 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: DATA TRIANGULATION

FIGURE 4 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT

FIGURE 5 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BOTTOM UP APPROACH

FIGURE 6 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: TOP DOWN APPROACH

FIGURE 7 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: INTERVIEWS BY REGION AND DESIGNATION

FIGURE 8 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: END USER COVERAGE GRID

FIGURE 11 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: THE CATEGORY VS TIME GRID

FIGURE 12 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET SEGMENTATION

FIGURE 13 GROWING PREVALENCE OF CHRONIC INFECTIOUS DISEASES , EXPANSION OF SYNTHETIC BIOLOGY AND RISING ADOPTION OF GENE THERAPY ARE EXPECTED TO DRIVE THE MARKET FOR MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET IN THE FORECAST PERIOD OF 2022 TO 2029

FIGURE 14 SYNTHESIZER SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET IN 2022 & 2029

FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET

FIGURE 16 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, 2021

FIGURE 17 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, 2022-2029 (USD MILLION)

FIGURE 18 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, CAGR (2022-2029)

FIGURE 19 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT, LIFELINE CURVE

FIGURE 20 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2021

FIGURE 21 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, 2022-2029 (USD MILLION)

FIGURE 22 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, CAGR (2022-2029)

FIGURE 23 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE TYPE, LIFELINE CURVE

FIGURE 24 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2021

FIGURE 25 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, 2022-2029 (USD MILLION)

FIGURE 26 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, CAGR (2022-2029)

FIGURE 27 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY GENE SYNTHESIS TYPE, LIFELINE CURVE

FIGURE 28 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2021

FIGURE 29 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, 2022-2029 (USD MILLION)

FIGURE 30 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, CAGR (2022-2029)

FIGURE 31 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY APPLICATION, LIFELINE CURVE

FIGURE 32 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2021

FIGURE 33 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, 2022-2029 (USD MILLION)

FIGURE 34 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, CAGR (2022-2029)

FIGURE 35 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY METHOD, LIFELINE CURVE

FIGURE 36 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, 2021

FIGURE 37 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, 2021-2029 (USD MILLION)

FIGURE 38 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, CAGR (2022-2029)

FIGURE 39 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY END USER, LIFELINE CURVE

FIGURE 40 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2021

FIGURE 41 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2022-2029 (USD MILLION)

FIGURE 42 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)

FIGURE 43 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 44 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: SNAPSHOT (2021)

FIGURE 45 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021)

FIGURE 46 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2022 & 2029)

FIGURE 47 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COUNTRY (2021 & 2029)

FIGURE 48 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: BY COMPONENT (2022-2029)

FIGURE 49 MIDDLE EAST & AFRICA GENE SYNTHESIS MARKET: COMPANY SHARE 2021 (%)

查看详细信息

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

What is the future value of the Market?

The Middle East and Africa Gene Synthesis Market value is expected USD 166.43 million by 2029.

What is the growth rate of the Market?

The Middle East and Africa Gene Synthesis Market is to grow at a CAGR of 17.4% during the forecast by 2029.

Who are the major players operating in the market?

The major players operating in the Middle East and Africa Gene Synthesis Market are Genescript, Synbio Technologies, Proteogenix, Bio Basic Inc., ATG: biosynthetic GmbH, Merck KGaA, Ginkgo Bioworks, Evonetix, ProMab Biotechnologies, Inc., CSBio, and Azenta US, Inc., among others.

What are the major countries covered in the Market?

The major countries covered in the Middle East and Africa Gene Synthesis Market are South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of the Middle East, and Africa.

Forecast Period	2022 –2029
Market Size (Base Year)	USD 45.53 Million
Market Size (Forecast Year)	USD 166.43 Million
CAGR	17.40 %
Major Markets Players	Dummy1 Dummy2 Dummy3 Dummy4 Dummy5 Request For Unlock

中东和非洲基因合成市场 – 行业趋势和 2029 年预测

中东和非洲基因合成市场 – 行业趋势和 2029 年预测

Middle East And Africa Gene Synthesis Market

CAGR : 17.40 %

中东和非洲基因合成市场分析与洞察

基因合成市场动态

中东和非洲基因合成市场范围

基因合成市场区域分析/见解

竞争格局和基因合成市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

报告

市场洞察

支持

解决方案

中东和非洲基因合成市场 – 行业趋势和 2029 年预测

中东和非洲基因合成市场 – 行业趋势和 2029 年预测

Middle East And Africa Gene Synthesis Market

CAGR : 17.40 %

中东和非洲基因合成市场分析与洞察

基因合成市场动态

中东和非洲基因合成市场范围

基因合成市场区域分析/见解

竞争格局和基因合成市场份额分析

Get online access to the report on the World's First Market Intelligence Cloud

目录

表格列表

图片列表

研究方法

可定制

Frequently Asked Questions

浏览相关页面